Risk warning: Our products are leveraged and carry a high level of risk, which can result in the loss of your entire capital. Such products may not be suitable for all investors. It is crucial to understand the risks involved fully.
  • Support
  • For Institutionals
Risk warning: Our products are leveraged and carry a high level of risk, which can result in the loss of your entire capital. Such products may not be suitable for all investors. It is crucial to understand the risks involved fully.
  • Support
  • For Institutionals

Current region:

  • English
    ACTIVE
Other languages:
  • Español – Spanish
  • Português – Portuguese
  • English – International
  • 日本語 – Japanese
Risk warning: Our products are leveraged and carry a high level of risk, which can result in the loss of your entire capital. Such products may not be suitable for all investors. It is crucial to understand the risks involved fully.
Risk Warning: Leveraged products carry a high level of risk and may result in the loss of all your capital. Ensure you fully understand the risks before investing.
Risk Warning: Leveraged products carry a high level of risk and may result in the loss of all your capital. Ensure you fully understand the risks before investing.

Current region:

  • English
    ACTIVE
Other languages:
  • Español – Spanish
  • Português – Portuguese
  • English – International
  • 日本語 – Japanese
Risk Warning: Leveraged products carry a high level of risk and may result in the loss of all your capital. Ensure you fully understand the risks before investing.

Novo Nordisk and UnitedHealth in Focus

Key Points to Watch Out For:

  • Novo Nordisk shares advance following FDA approval.
  • Soho House jumps 13% in premarket trading on privatization deal.
  • UnitedHealth rises 3% in premarket after Berkshire stake disclosure.

Novo Nordisk (NVO): FDA Approval for Wegovy

The FDA approved Wegovy for the treatment of a form of liver disease. Shares gained nearly 5.5% in Denmark. Wegovy, already known as a weight-loss drug, is now cleared for this additional indication, strengthening Novo Nordisk’s market position.

Soho House (SHCO): Move to Go Private

A group of investors, including one of the largest U.S. hotel owners, is nearing an agreement to take the company private, according to The Wall Street Journal. Shares rose 13% in premarket trading. Soho House, which operates membership-based clubs, is reportedly close to finalizing the deal.

UnitedHealth (UNH): Premarket Gains After Berkshire Disclosure

Shares of UnitedHealth climbed 3% in premarket trading, extending Friday’s rally after Berkshire Hathaway disclosed a stake in the health insurer. The move reflects positive investor sentiment toward Berkshire’s portfolio adjustments.

First Solar (FSLR) and SunRun (RUN): Solar Sector Rebound

Solar stocks advanced in premarket trading, building on Friday’s gains after updated clean energy tax credit guidance proved less restrictive than expected. Vestas Wind Systems and Ørsted also rebounded in Denmark, underscoring broad sector momentum across renewable energy companies.

Dayforce (DAY): Buyout Interest from Thoma Bravo

Shares of Dayforce surged more than 35% in premarket trading following a Bloomberg report that Thoma Bravo is in talks to acquire the HR software provider. The stock reacted strongly to news of the potential buyout negotiations.

Grand Canyon Education (LOPE): FTC Case Dismissed

The Federal Trade Commission dropped a complaint dating back to the Biden administration that accused Grand Canyon Education of falsely presenting itself as a non-profit. The dismissal effectively closes the case, removing a regulatory overhang on the company.

Palo Alto Networks (PANW): Earnings and CyberArk Acquisition

Palo Alto Networks is set to report quarterly results after the close. The cybersecurity firm also recently announced a $25 billion acquisition of CyberArk Software. The dual update highlights both earnings performance and strategic expansion in the cybersecurity sector.

Related posts

Technical Analysis-EN

Silver Tests Critical $61 Support

Gold remains technically fragile after failing to reclaim the key $4,365 resistance level. The previous swing low around $4,100, established

Nasdaq Leads Tech Stocks Fuel Market Rebound

Nasdaq Leads; Tech Fuels Market Rebound

U.S. stocks closed higher, ending a holiday-shortened trading week in positive territory as investors moved back into equities after the

Technical Analysis-EN

BTCXAU Ratio Near Long-Term Support

Analysing assets in gold terms is a common approach used to assess value relative to a tangible monetary benchmark. Expressing